Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
K. N. Rose(Harvard University), Stephen N. Gomperts(Harvard University), Aline Fassini(Harvard University), Xiaochang Xue(Massachusetts General Hospital), Hyowon Lee(Massachusetts General Hospital), Sung‐Han Lin(Massachusetts General Hospital), Pia Kivisäkk(Harvard University), M. A. Schwarzschild(Harvard University), Waijiao Cai(Massachusetts General Hospital), Musab M. Zorlu(Massachusetts General Hospital), Xiqun Chen(Harvard University)
Cited by 20
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
|Neurology|2020|772
Validating novel tau positron emission tomography tracer <scp>[F‐18]‐AV‐1451 (T807)</scp> on postmortem brain tissue
|Annals of Neurology|2015|626
Imaging amyloid deposition in Lewy body diseases
|Neurology|2008|446
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
|Newcastle University ePrints (Newcastle Univesity)|2017|379